Education
About Us
Working with TipRanks
Follow Us
Bajaj Healthcare Ltd (IN:BAJAJHCARE)
:BAJAJHCARE
BAJAJHCARE Stock Chart & Stats
₹418.50
-₹31.80(-5.51%)
At close: 4:00 PM EST
₹418.50
-₹31.80(-5.51%)
Day’s Range― - ―
52-Week Range₹306.75 - ₹744.90
Previous CloseN/A
Volume215.90K
Average Volume (3M)4.99K
Market Cap
₹9.96B
Enterprise Value₹12.14B
Total Cash (Recent Filing)₹44.51M
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)20.9
Beta1.02
Next Earnings
Jun 02, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.24%
Share Statistics
EPS (TTM)4.96
Shares Outstanding31,583,252
10 Day Avg. Volume2,706
30 Day Avg. Volume4,987
Financial Highlights & Ratios
PEG Ratio-0.38
Price to Book (P/B)4.64
Price to Sales (P/S)3.98
P/FCF Ratio-124.79
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Product And Market DiversificationBajaj Healthcare operates across APIs, intermediates and finished formulations and sells domestically and for export. This diversified mix reduces customer and product concentration risk, supports cross‑sell and vertical integration, and helps stabilize revenues over multiple quarters.
Revenue Growth TrendReported revenue growth of ~17.3% indicates expanding sales momentum and market demand for the company's products. Sustained top‑line growth supports scale economies, aids margin recovery potential and provides resources to invest in capacity and quality controls that sustain competitiveness.
Improving Equity RatioAn improving equity ratio points to a strengthening capital structure versus earlier periods. Over the medium term this enhances solvency, improves borrowing terms, and gives management more flexibility to deleverage, invest in capacity or withstand industry cyclicality without immediate liquidity strain.
Bears Say
High LeverageA relatively high debt‑to‑equity ratio increases financial risk by raising interest costs and refinancing exposure. Persistently elevated leverage constrains capital allocation, limits strategic flexibility, and makes earnings and cash flows more sensitive to cyclical downturns or higher input costs over the medium term.
Inconsistent Cash GenerationInconsistent operating cash flow and recent negative free cash flow reduce the firm's ability to self‑fund growth, service debt or invest in quality/capacity. Reliance on external financing raises liquidity and refinancing risk and can force tradeoffs in capex, R&D or working capital over multiple quarters.
Margin Pressure And Revenue VolatilityDeclining gross and EBIT margins alongside fluctuating revenue point to cost pressures, pricing weakness or mix shifts that compress durable profitability. Persistent margin erosion erodes cash conversion and leaves less buffer to absorb shocks, complicating strategic investments and long‑term planning.
Bajaj Healthcare Ltd News
BAJAJHCARE FAQ
What was Bajaj Healthcare Ltd’s price range in the past 12 months?
Bajaj Healthcare Ltd lowest stock price was ₹306.75 and its highest was ₹744.90 in the past 12 months.
What is Bajaj Healthcare Ltd’s market cap?
Bajaj Healthcare Ltd’s market cap is ₹9.96B.
When is Bajaj Healthcare Ltd’s upcoming earnings report date?
Bajaj Healthcare Ltd’s upcoming earnings report date is Jun 02, 2026 which is in 84 days.
How were Bajaj Healthcare Ltd’s earnings last quarter?
Bajaj Healthcare Ltd released its earnings results on Jan 16, 2026. The company reported ₹4.963 earnings per share for the quarter, beating the consensus estimate of N/A by ₹4.963.
Is Bajaj Healthcare Ltd overvalued?
According to Wall Street analysts Bajaj Healthcare Ltd’s price is currently Overvalued.
Does Bajaj Healthcare Ltd pay dividends?
Bajaj Healthcare Ltd pays a Annually dividend of ₹1 which represents an annual dividend yield of 0.24%. See more information on Bajaj Healthcare Ltd dividends here
What is Bajaj Healthcare Ltd’s EPS estimate?
Bajaj Healthcare Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Bajaj Healthcare Ltd have?
Bajaj Healthcare Ltd has 31,583,252 shares outstanding.
What happened to Bajaj Healthcare Ltd’s price movement after its last earnings report?
Bajaj Healthcare Ltd reported an EPS of ₹4.963 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -0.8%.
Which hedge fund is a major shareholder of Bajaj Healthcare Ltd?
Currently, no hedge funds are holding shares in IN:BAJAJHCARE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Bajaj Healthcare Ltd
Bajaj HealthCare Limited, a pharmaceutical company, develops, manufactures, and supplies amino acids, nutritional supplements, and active pharmaceutical ingredients (APIs) for pharmaceutical, nutraceuticals, and food industries in India and internationally. The company's product portfolio consists of various APIs in the therapeutic categories of anti-diabetic, antibiotic, antiviral, antiplatelet, antifungal, antihelmintic, iron-chelating agent, anticonvulsant, growth stimulant, non-steroidal anti-inflammatory drugs, antihypertensive, anthelmintics, anti-asthmatic, antioxidant, urinary tract infection, anti-histamine, weight reducing, venous disease, antimalarial, vitamin c, disinfectant/ antiseptic, stimulant, anticonvulsant, lipotropic agents, nootropic, vasoprotective/ antihemorrhagic, cardiovascular agent, food supplements, anti-anemic, amino acids, antiasthmatic / bronchodilator, nutritional supplement, and minerals. It also provides formulations in the form of tablets, capsules, and powder, as well as impurities. In addition, the company exports its products. Bajaj HealthCare Limited was incorporated in 1993 and is based in Thane, India.
Technical Analysis
Bliss Gvs Pharma Limited
―
Hester Biosciences Limited
―
Jagsonpal Pharmaceuticals Ltd.
―
Syncom Formulation (India) Ltd.
―
Themis Medicare Limited
―